February 23, 2022
EmsanaRx, a pharmacy benefit manager launched by the Purchaser Business Group on Health, started operations in January.
Catch up on all the latest in ADHD from the virtual APSARD 2022 Annual Meeting.
February 22, 2022
A new report by Cardinal Health includes research findings on insulin biosimilars use among retail pharmacists and physicians.
Cariprazine is already approved to treat schizophrenia and bipolar I in adults.
February 21, 2022
Apetamin has been promoted worldwide as a weight gain supplement—but what are the dangers of misuse?
February 18, 2022
Zuranolone treatment in patients with major depressive disorder demonstrates a rapid and statistically significant reduction in depressive symptoms.
February 17, 2022
Health care and social workers combined for more injuries and illnesses than any other industry in the nation.
February 15, 2022
Industry and investors are focusing on other segments despite the need for new therapeutics
February 11, 2022
Your weekly roundup of the latest news from Drug Topics®.
February 10, 2022
The move is supported by data from a Phase 3 trial that evaluated the efficacy and safety of dupilumab in addition to standard-of-care topical corticosteroids.
